Mucin disulfide bond

The mucin disulfide bond is a critical structural element within mucus glycoproteins, primarily MUC5AC and MUC5B, which are the major gel-forming components of human airway mucus (Thornton et al., 2002, PubMed: 11850410). These covalent cross-links occur between the cysteine-rich domains of mucin monomers, facilitating the formation of a high-molecular-weight polymer network that gives mucus its characteristic viscoelastic properties (StatPearls, 2023, NBK537183). In respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), hypersecretion and oxidative stress lead to excessive cross-linking, resulting in thick, tenacious mucus that impairs mucociliary clearance (DrugBank, 2024, DB01151). Pharmacological targeting of these bonds is achieved through mucolytic agents like N-acetylcysteine, which contain free sulfhydryl groups (Sadowska, 2012, PubMed: 22530931). These drugs act as reducing agents, breaking the disulfide bridges and converting them into sulfhydryl groups, thereby depolymerizing the mucin network (NCBI, 2023, NBK537183). This reduction in mucus viscosity facilitates easier expectoration and improves airway patency for patients with obstructive lung conditions. Beyond respiratory health, these bonds are also relevant in gastric mucus protection and various mucosal surfaces where mucus integrity is vital for barrier function (Thornton et al., 2002, PubMed: 11850410). Therapeutic intervention specifically aims to modulate the physical state of the mucus without necessarily altering the underlying protein synthesis.

Other names

Mucus glycoprotein disulfide bondMucin cross-linkDisulfide bridge in mucinMucoprotein disulfide bond

Reduction of intermolecular disulfide bonds between mucin monomers, leading to the depolymerization of the mucus gel and a decrease in its viscosity.